Axicabtagene ciloleucel Intravenous and Vaccination
Result of checking the interaction of drug Axicabtagene ciloleucel Intravenous and disease Vaccination for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:The safety of immunization with live viral vaccines during or following treatment with drugs directed against B cells, such as axicabtagene ciloleucel, and tisagenlecleucel has not been studied. Vaccination with live virus vaccines is not recommended for at least 6 weeks prior to the start of lymphodepleting chemotherapy, during treatment, and until immune recovery following treatment with these agents.
Generic Name: axicabtagene ciloleucel
Brand Name: Yescarta
Synonyms: Axicabtagene ciloleucel, Axicabtagene Ciloleucel